The potential impact of platelet growth factors in transfusion medicine

Jeffrey McCullough

Research output: Contribution to journalArticlepeer-review

Abstract

The long-sought platelet growth factor, thrombopoietin, has been identified, the gene cloned, and the molecule is now available for clinical use. Thrombopoietin may be useful in transfusion medicine by: 1) reducing the demand for platelets by decreasing the severity and duration of thrombocytopenia, 2) reducing the time required for platelet donation, thus making more platelet donors available, 3) increasing the number of platelets that can be collected from existing platelet donors, 4) increasing the yield of peripheral blood stem cells through synergy with other hematopoietic growth factors, 5) expanding progenitor cells ex vivo through its effect on early progenitors, and 6) producing platelets in ex vivo culture systems.

Original languageEnglish (US)
Pages (from-to)386-390
Number of pages5
JournalCurrent opinion in hematology
Volume5
Issue number6
DOIs
StatePublished - Jan 1 1998

Fingerprint Dive into the research topics of 'The potential impact of platelet growth factors in transfusion medicine'. Together they form a unique fingerprint.

Cite this